Clinical Notebook n°2 - PhysioAssist

Conclusions

Patients with various chronic obstructive lung diseases acquired quickly autonomous usage of the device during hospitalization

after a short training by physiotherapists. The technology was very well tolerated in all patients who ﬁnd it comfortable and easy

to use. No signiﬁcant side eﬀect related to Simeox device was reported in the series. These data conﬁrm the feasibility and safety

of Simeox technology in patients suﬀering of bronchial congestion and requiring chest physiotherapy.

Mucus clearance and respiratory symptoms improved to the same extent as manual physiotherapy after a few days of therapy.

In some series, mucus production was increased with Simeox after manual physiotherapy trial. These results suggest that Simeox

can do as much or better than conventional physiotherapy for airway clearance management in patients hospitalized for acute

exacerbation and are in favor of promoting this technology as an alternative of conventional ACTs.

Moreover, Simeox device may provide also additional beneﬁts on lung function and quality of life in patients with COPD and/or

bronchiectasis. These interesting data deserve to be investigated in more detail in the near future to understand deeply the

beneﬁts of Simeox technology.

References

1. Holland AE, Button BM. Is there a role for airway clearance techniques in chronic obstructive pulmonary disease? Chronic

Respiratory Disease. 2006/05/30 2006; Vol. 3, issue 2:83 91.

2. McIlwaine M, Bradley J, Elborn JS, et al. Personalizing airway clearance in chronic lung disease. Eur Respir Rev 2017; 26: 160086

[https://doi.org/10.1183/16000617.0086-2016].

3. Van der Schans C, Prasad A, Main E. Chest physiotherapy compared to no chest physiotherapy for cystic ﬁbrosis. Cochrane

Database Syst Rev 2000;(2):CD001401.

4. Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane

Database of Systematic Reviews 2012, Issue 3. Art. No.: CD008328. DOI: 10.1002/14651858.CD008328.pub2.

5. Main E, Prasad A, van der Schans CP. Conventional chest physiotherapy compared to other airway clearance techniques for cystic

ﬁbrosis. Cochrane Database Syst Rev 2005;1:CD002011.

6. Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic ﬁbrosis. Cochrane Database Syst Rev

2009;1:CD006842.

7. Flume PA, Robinson KA, O Sullivan BP, Finder JD, Vender RL, Willey-Courand DB, White TB, Marshall BC, and the Clinical Practice

Guidelines for Pulmonary Therapies Committee Cystic Fibrosis Pulmonary Guidelines: Airway Clearance Therapies. Respir Care

2009;54(4): 522 537

8. McIlwaine M, Button B, Dwan K. Positive expiratory pressure physiotherapy for airway clearance in people with cystic ﬁbrosis.

Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD003147. DOI: 10.1002/14651858.CD003147.pub4.

9. Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews 2015, Issue

11. Art. No.: CD008351. DOI: 10.1002/14651858.CD008351.pub3.

10. Mascardi V, Grecchi B, Barlascini C, Banﬁ P, Nicolini A. Eﬀectiveness of temporary positive expiratory pressure (T-PEP) at home

and at hospital in patients with severe chronic obstructive pulmonary disease. J Thorac Dis 2016;8(10):2895-2902. doi:

10.21037/jtd.2016.10.69

11. Nicolini A, Mascardi V, Grecchi B, Ferrari-Bravo M, Banﬁ P, Barlascini C. Comparison of eﬀectiveness of temporary positive

expiratory pressure versus oscillatory positive expiratory pressure in severe COPD patients. Clin Respir J. 2017;00:1 9.

https://doi.org/10.1111/crj.12661 40